Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CXCR2 | P25025 | 11/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | CCR6 | P51684 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.46 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15534968 | 0.83 | MEN1 (0.54) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 | |
| SCHEMBL1446966 | 0.83 | MEN1 (0.57) | MEN1KMT2ASMN1; SMN2KEAP1ALDH1A1 | |
| SCHEMBL12625964 | 0.82 | ALDH1A1 (0.62) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 | |
| SCHEMBL4125084 | 0.82 | SMN1; SMN2 (0.47) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 | |
| SCHEMBL1706450 | 0.80 | MMP2 (0.60) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 | |
| SCHEMBL15069131 | 0.80 | MEN1 (0.46) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 | |
| SCHEMBL245254 | 0.80 | FNTA (0.58) | KMT2ASMN1; SMN2ALOX5TERTADAMTS4 | |
| SCHEMBL12633448 | 0.77 | CXCR2 (0.57) | CXCR2CCR6CXCR1 | |
| SCHEMBL12633743 | 0.77 | CXCR2 (0.43) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 | |
| SCHEMBL12569568 | 0.77 | GABRA1 (0.55) | MEN1KMT2ASMN1; SMN2CXCR2KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005099782-A1 | COMPOSITION COMPRISING INTERCALATED METAL-ION SEQUESTRANTS | EASTMAN KODAK COMPANY (US) | 2005-10-27 | — | — | WO | claimed |
| US-20050228103-A1 | Composition comprising intercalated metal-ion sequestrants | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| CN-107532075-B | Oil and gas treatment compositions comprising hydroxyethyl cellulose and crosslinked polyvinylpyrrolidone | 赫尔克里士有限公司 | 2022-03-08 | — | — | CN | disclosed |
| EP-3847889-A1 | BIOCIDAL COMPOSITIONS COMPRISING IRON CHELATORS | Arch Chemicals, Inc. (US) | 2021-07-14 | — | — | EP | disclosed |
| US-10973228-B2 | Eco-friendly non-aqueous antimicrobial composition comprising hinokitiol with 1,3-propanediol and/or sorbitan caprylate | ISP INVESTMENTS LLC (US) | 2021-04-13 | — | — | US | disclosed |
| US-20200170249-A1 | Biocidal Compositions Comprising Iron Chelators | ARCH CHEMICALS, INC. | 2020-06-04 | — | — | US | disclosed |
| US-10433548-B2 | Biocidal compositions comprising iron chelators | ARCH CHEMICALS, INC. (US) | 2019-10-08 | — | — | US | disclosed |
| US-10113099-B2 | High pressure high temperature (HPHT) aqueous drilling mud composition and process for preparing the same | ISP INVESTMENTS LLC (US) | 2018-10-30 | — | — | US | disclosed |
| EP-2879492-B1 | ECO-FRIENDLY NON-AQUEOUS ANTIMICROBIAL COMPOSITION COMPRISING HINOKITIOL WITH 1,3-PROPANEDIOL OR SORBITAN CAPRYLATE | ISP INVESTMENTS INC (US) | 2018-10-03 | — | — | EP | disclosed |
| EP-2879499-B1 | ECO-FRIENDLY NON-AQUEOUS ANTIMICROBIAL COMPOSITION COMPRISING TROPOLONE WITH 1,3-PROPANEDIOL OR SORBITAN CAPRYLATE | ISP INVESTMENTS INC (US) | 2018-09-26 | — | — | EP | disclosed |
| US-9969921-B2 | Oil and gas treatment composition comprising hydroxyethyl cellulose and crosslinked polyvinylpyrrolidone | HERCULES LLC (US) | 2018-05-15 | — | — | US | disclosed |
| US-20050226913-A1 | Article for inhibiting microbial growth in physiological fluids | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | disclosed |
| US-20050227016-A1 | Container for inhibiting microbial growth in liquid nutrients | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | disclosed |
| US-20050228099-A1 | Composition of matter comprising polymer and derivatized nanoparticles | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | disclosed |
| US-20050224417-A1 | Use of derivatized nanoparticles to minimize growth of micro-organisms in hot filled drinks | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | disclosed |
| US-20050224425-A1 | Container for inhibiting microbial growth in liquid nutrients | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | disclosed |
| EP-1567156-A2 | HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS | RELIVIA SRL (IT) | 2005-08-31 | — | — | EP | disclosed |
| US-20050129929-A1 | Antimicrobial metal-ion sequestering web for application to a surface | EASTMAN KODAK COMPANY | 2005-06-16 | — | — | US | disclosed |
| WO-2004045609-A2 | HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS | RELIVIA SRL (IT) | 2004-06-03 | — | — | WO | disclosed |
| US-5049280-A | 2,3-dihydroxyterephthalamides as highly effective metal ion sequestering compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226913-A1 | Article for inhibiting microbial growth in physiological fluids | FABP2, FABP1, MIF | MEN1 1347/4885KMT2A 3532/4885SMN1; SMN2 4795/4885 |
| US-10973228-B2 | Eco-friendly non-aqueous antimicrobial composition comprising hinokitiol with 1,3-propanediol and/or sorbitan caprylate | EBP, TRPV1, TES | MEN1 3236/4885KMT2A 4305/4885SMN1; SMN2 2743/4885 |
| US-10433548-B2 | Biocidal compositions comprising iron chelators | SLC40A1, TFRC, SLC39A14 | MEN1 3469/4885KMT2A 3844/4885SMN1; SMN2 4497/4885 |
| US-20200170249-A1 | Biocidal Compositions Comprising Iron Chelators | SLC40A1, TFRC, SLC39A14 | MEN1 3469/4885KMT2A 3844/4885SMN1; SMN2 4497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.